
Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

More and more, treating HER2-positive breast cancers involves combining an array of drugs.

According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.

Published: March 11th 2015 | Updated:

Published: October 18th 2017 | Updated:

Published: June 20th 2018 | Updated: